Nordic Nanovector
Committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.
Launch date
Employees
Market cap
€32.2m
Enterprise valuation
€23m (Public information from Jun 2023)
Share price
NOK1.018 NANOV.F
Oslo Norway (HQ)
Financials
Estimates*
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | - | <1m | 1.0m | <1m | - | 11.8m |
% growth | (40 %) | - | - | 11 % | (40 %) | - | - |
EBITDA | (20.0m) | (34.7m) | (30.0m) | (40.0m) | (40.0m) | - | (<1m) |
% EBITDA margin | (66667 %) | - | (3333 %) | (4000 %) | (6667 %) | - | (6 %) |
Profit | 20.0m | (32.3m) | 20.0m | 30.0m | 30.0m | (34.2m) | (2.9m) |
% profit margin | 66667 % | - | 2222 % | 3000 % | 5000 % | - | (25 %) |
EV / revenue | - | - | - | - | - | - | 2.4x |
EV / EBITDA | - | - | - | - | - | - | -38.0x |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
N/A | N/A | IPO | |
N/A | Grant | ||
$1.3m | Grant | ||
N/A | $42.5m | Private Placement VC | |
* | N/A | NOK250m | Private Placement VC |
Total Funding | €67.3m |
Related Content
Recent News about Nordic Nanovector
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Nordic Nanovector
EditACQUISITION by Nordic Nanovector Jun 2023